Advances in the Biology of Lung Cancer Chemoprevention
Authors:
- 10 May 2005
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (14) , 3186-3197
Abstract
The heavy burden of lung cancer, which includes the highest worldwide mortality of any cancer, and its resistance to standard approaches (smoking cessation, screening, and therapy), have motivated an intense interest in chemoprevention of this disease. Randomized controlled trials of agents (including retinoids, beta-carotene, and vitamin E) to prevent lung cancer have produced only disappointing clinical results to date. New, molecular-targeted approaches are advancing rapidly, however, with many promising targets and interactive signaling pathways for developing novel agents and combinatorial approaches in this setting. This promise is illustrated by recent studies of 15-hydroxyprostaglandin dehydrogenase, which plays a critical role in polyunsaturated fatty acid metabolism and (like another important target, prostacyclin) is downstream of cyclooxygenase-2. 15-hydroxyprostaglandin dehydrogenase degrades prostaglandin E2, appears to have tumor suppressor activity, and can be induced both by peroxisome proliferator-activated receptor-gamma ligands and an epidermal growth factor receptor inhibitor. Other important targets/pathways include the insulin-like growth factor axis, phosphoinositide 3-kinase pathway, cyclin D and E family members, and epigenetic events. Defining highest lung cancer risk (eg, establishing molecular risk models through long-term analyses of high-risk cohorts) will facilitate the clinical development of molecular-targeted prevention that will potentially reduce the enormous burden of lung cancer.Keywords
This publication has 82 references indexed in Scilit:
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Represses Cyclin D1 in Aerodigestive Tract CancersClinical Cancer Research, 2004
- Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in MiceCancer Research, 2004
- Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates Activation of Cigarette Smoke-Induced Nuclear Factor (NF)-κB by Suppressing Activation of I-κB α Kinase in Human Non-Small Cell Lung CarcinomaCancer Research, 2004
- Crosstalk of oncogenic and prostanoid signaling pathwaysJournal of Cancer Research and Clinical Oncology, 2004
- Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenaseBiochemical and Biophysical Research Communications, 2004
- Histone deacetylase 1 represses the small GTPase RhoB expression in human nonsmall lung carcinoma cell lineOncogene, 2003
- Retinoic Acid Receptor and Telomerase Catalytic Subunit Expression in Bronchial Epithelium of Heavy SmokersJNCI: Journal of the National Cancer Institute, 2003
- Thromboxane A2 Regulation of Endothelial Cell Migration, Angiogenesis, and Tumor MetastasisBiochemical and Biophysical Research Communications, 2000
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by IsotretinoinNew England Journal of Medicine, 1995